Hyperphosphorylation of retinoblastoma protein and stimulation of growth by okadaic acid in human pancreatic cancer |
| |
Authors: | Aki Hirai MD Richard J. Bold MD Jin Ishizuka MD PhD Masashi Hirai MD Dr. Courtney M. Townsend Jr. MD James C. Thompson MD |
| |
Affiliation: | (1) Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan;(2) the University of California, Davis-East Bay, Oakland, California;(3) Department of Surgery, The University of Texas Medical Branch, 301 University Boulevard, 77555-0527 Galveston, Texas |
| |
Abstract: | Phosphorylation/dephosphorylation of intracellular proteins are important steps in the regulation of cell growth. Okadaic acid, an inhibitor of the serine/threonine protein phosphatases 1 and 2A, is a potent tumor promoter. This effect may be through the inhibition of dephosphorylation (termed hyperphosphorylation) and subsequent inactivation of tumor-suppressor proteins. We examined whether okadaic acid regulates growth of human pancreatic cancer cells (MIA PaCa-2 and Panc-1) or alters the phosphorylation of the retinoblastoma tumor-suppressor protein. Growth studies, nuclear labeling analyses, and Western blotting for retinoblastoma protein were performed. Okadaic acid stimulated cell growth and induced hyperphosphorylation of the retinoblastoma protein. The growth-stimulatory effect of okadaic acid on these human pancreatic cancer cells may be mediated by inactivation of the growth suppressive effect of the retinoblastoma protein by hyperphosphorylation. These studies suggest that the growth of these human pancreatic cancer cells is still regulated by tumor-suppressor proteins.This work was supported by grants from the National Institutes of Health (5P01 DK35608, 2R01 DK15241, T32 DK07639), the American Cancer Society (CB-571), and the John Sealy Memorial Endowment Fund. |
| |
Keywords: | okadaic acid retinoblastoma protein pancreatic cancer |
本文献已被 SpringerLink 等数据库收录! |
|